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Palladium(II) and platinum(II) complexes of general empirical formula, [M(NS)2] 
(NS=uninegatively charged acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate; 
M=PtII and PdII) have been prepared and characterized by a variety of physicochemical 
techniques. Based on conductance, IR and electronic spectral evidence, a square-planar 
structure is assigned to these complexes. The crystal and molecular structure of the 
[Pd(asme)2] complex (asme=anionic form of the acetone Schiff base of S-
methyldithiocarbazate) has been determined by X-ray diffraction. The complex has a 
distorted cis-square planar structure with the ligands coordinated to the palladium(II) ions as 
uninegatively charged bidentate NS chelating agents via the azomethine nitrogen and the 
mercaptide sulfur atoms. The distortion from a regular square-planar geometry is attributed to 
the restricted bite angles of the ligands. Antimicrobial tests indicate that the Schiff bases 
exhibit strong activities against the pathogenic bacteria, Bacillus subtilis (mutant defective 
DNA repair), methicillin-resistant Staphylococcus aureus, B. subtilis (wild type) and 
Pseudomonas aeruginosa and the fungi, Candida albicans (CA), Candida lypotica (2075), 
Saccharomyces cerevisiae (20341) and Aspergillus ochraceous (398)—the activities 
exhibited by these compounds being greater than that of the standard antibacterial and 
antifungal drugs, streptomycin and nystatin, respectively. The palladium(II) and platinum(II) 
complexes are inactive against most of these organisms but, the microbe, Pseudomonas 
aeruginosa shows strong sensitivity to the platinum(II) complexes. Screening of the 
compounds for their cytotoxicities against T-lymphoblastic leukemia cancer cells has shown 
that the acetone Schiff base of S-methyldithiocarbazate (Hasme) exhibits a very weak 
activity, whereas the S-benzyl derivative (Hasbz) is inactive. However, the palladium(II) 
complexes exhibit strong cytotoxicities against this cancer; their activities being more than 
that of the standard anticancer drug, tamoxifen. The [Pt(asme)2] complex exhibits a very 
weak cytotoxicity, whereas [Pt(asbz)2] is inactive against leukemic cells. 
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